Glenn Noronha
Corporate Officer/Principal chez The Association for Research in Vision & Ophthalmology
Profil
Glenn Noronha is a professional with a doctorate degree from Loyola University of Chicago.
He is currently a member of The Association for Research in Vision & Ophthalmology.
In the past, he held positions such as Associate Director-Medicinal Chemistry at TargeGen, Project Head-Global Retinal Development at Alcon Laboratories, Vice President-Research & Development at Sucampo Pharma Americas, and Chief Scientific Officer at Clearside Biomedical, Theriac Pharma Corp., JW Therapeutics (Shanghai) Co., Ltd., Navire Pharma, Inc., and BridgeBio Pharma, Inc. He was also a Research Scientist & Project Leader at Medtronic MiniMed, Inc. from 2000 to 2002.
He will be the Chief Development Officer at PYC Therapeutics Ltd.
from 2021 to 2023.
Postes actifs de Glenn Noronha
| Sociétés | Poste | Début |
|---|---|---|
The Association for Research in Vision & Ophthalmology
 The Association for Research in Vision & Ophthalmology Miscellaneous Commercial ServicesCommercial Services The Association for Research in Vision & Ophthalmology operates an association focused on research in vision and ophthalmology. The non-profit company is based in Rockville, MD. | Corporate Officer/Principal | - |
Anciens postes connus de Glenn Noronha
| Sociétés | Poste | Fin |
|---|---|---|
| PYC THERAPEUTICS LIMITED | Corporate Officer/Principal | 01/01/2023 |
| CLEARSIDE BIOMEDICAL, INC. | Chief Tech/Sci/R&D Officer | 01/12/2018 |
| Sucampo Pharma Americas, Inc. | Chief Tech/Sci/R&D Officer | 01/05/2013 |
| Theriac Pharma Corp. | Chief Tech/Sci/R&D Officer | 01/07/2012 |
Alcon Laboratories, Inc.
 Alcon Laboratories, Inc. Medical SpecialtiesHealth Technology Alcon Laboratories, Inc. develops and manufactures ophthalmic pharmaceutical products. The firm offers over-the-counter eye care products, medical devices, equipment, ophthalmic drugs, surgical instruments, needles, and sutures for microsurgery and disposable drapes. The company was founded by Robert Alexander and William Conner in 1945 and is headquartered in Fort Worth, TX. | Corporate Officer/Principal | 01/01/2011 |
Formation de Glenn Noronha
| Loyola University of Chicago | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| PYC THERAPEUTICS LIMITED | Health Technology |
| CLEARSIDE BIOMEDICAL, INC. | Health Technology |
| BRIDGEBIO PHARMA, INC. | Health Technology |
| Entreprise privées | 8 |
|---|---|
TargeGen, Inc.
 TargeGen, Inc. Pharmaceuticals: MajorHealth Technology TargeGen, Inc. manufactures vascular biopharmaceutical products. The company was founded by David A. Cheresh and Peter G. Ulrich in 2001 and is headquartered in San Diego, CA. | Health Technology |
Alcon Laboratories, Inc.
Alcon Laboratories, Inc. Medical SpecialtiesHealth Technology Alcon Laboratories, Inc. develops and manufactures ophthalmic pharmaceutical products. The firm offers over-the-counter eye care products, medical devices, equipment, ophthalmic drugs, surgical instruments, needles, and sutures for microsurgery and disposable drapes. The company was founded by Robert Alexander and William Conner in 1945 and is headquartered in Fort Worth, TX. | Health Technology |
Medtronic MiniMed, Inc.
 Medtronic MiniMed, Inc. Medical SpecialtiesHealth Technology Medtronic MiniMed, Inc. manufactures insulin pumps and glucose monitoring systems. Its products include minimed 530g system, smartguard, enlite sensor, minimed revel and infusion sets. The company was founded by Alfred E. Mann in 1979 and is headquartered in Northridge, CA. | Health Technology |
The Association for Research in Vision & Ophthalmology
The Association for Research in Vision & Ophthalmology Miscellaneous Commercial ServicesCommercial Services The Association for Research in Vision & Ophthalmology operates an association focused on research in vision and ophthalmology. The non-profit company is based in Rockville, MD. | Commercial Services |
| Sucampo Pharma Americas, Inc. | |
| Theriac Pharma Corp. | |
JW Therapeutics (Shanghai) Co., Ltd.
 JW Therapeutics (Shanghai) Co., Ltd. BiotechnologyHealth Technology JW Therapeutics (Shanghai) Co., Ltd. engages in biopharmaceutical industry. It focuses on the development, transformation, and promotion of cell-based immunotherapies to treat cancer. The company was founded by Yi Ping Li on February 18, 2016 and is headquartered in Shanghai, China. | Health Technology |
Navire Pharma, Inc.
 Navire Pharma, Inc. Pharmaceuticals: MajorHealth Technology Navire Pharma, Inc. engages in the development of therapeutics to treat multiple cancers. It focuses on SHP2, a protein-tyrosine phosphatase that links growth factor, cytokine and integrin signalling with the downstream RAS/ERK MAPK pathway to regulate cellular proliferation and survival. The company was founded by Phil Jones and Benjamin Neel in 2017 and is headquartered in San Francisco, CA. | Health Technology |
